Evogene Ltd. (TLV:EVGN)
343.60
-3.20 (-0.92%)
At close: Dec 4, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2007 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2007 - 2019 |
| Agriculture | 5.89M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Agriculture Growth | 55.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Industrial Applications | 2.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Industrial Applications Growth | 106.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated | 323.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated Growth | 12.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Human Health | 80.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Human Health Growth | -83.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2007 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2007 - 2019 |
| United States | 3.92M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 6.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Israel | 595.77K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Israel Growth | -33.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 4.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 273.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Brazil | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Brazil Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|